Achillion Pharmaceuticals, Inc. (ACHN) Soars: Stock Up 10.2%

Zacks

Achillion Pharmaceuticals, Inc. (ACHN) was a big mover last session, as its shares rose over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend of the healthcare company since Jan 27, as the stock is now trading above the volatile price range of $3.08 to $3.46.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Achillion currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gentium S.p.A (GENT), Emergent BioSolutions, Inc. (EBS) and Actelion Ltd. (ALIOF). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




ACHILLION PHARMACEUTICALS INC (ACHN): Free Stock Analysis Report

GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report

EMERGENT BIOSOLUTIONS INC (EBS): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)